Education
About Us
Working with TipRanks
Follow Us
Global Cord Blood (CORBF)
OTHER OTC:CORBF
Total Valuation
Global Cord Blood has a market cap or net worth of $140.61M. The enterprise value is ―.
Market Cap$140.61M
Enterprise Value―
Share Statistics
Global Cord Blood has 133,914,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding133,914,720
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Global Cord Blood’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.26%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.26%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.03M
Profits Per Employee423.86K
Employee Count1,202
Asset Turnover0.15
Inventory Turnover4.00
Valuation Ratios
The current PE Ratio of Global Cord Blood is 5.92. Global Cord Blood’s PEG ratio is ―.
PE Ratio5.92
PS Ratio0.00
PB Ratio0.14
Price to Fair Value0.61
Price to FCF1.31
Price to Operating Cash Flow1.15
PEG Ratio―
Income Statement
In the last 12 months, Global Cord Blood had revenue of 1.24B and earned 501.06M in profits. Earnings per share was 4.12.
Revenue1.24B
Gross Profit1.06B
Operating Income608.87M
Pretax Income627.84M
Net Income501.06M
EBITDA656.79M
Earnings Per Share (EPS)4.12
Cash Flow
In the last 12 months, operating cash flow was 290.37M and capital expenditures 0.00, giving a free cash flow of 290.37M billion.
Operating Cash Flow290.37M
Free Cash Flow290.37M
Free Cash Flow per Share2.17
Dividends & Yields
Global Cord Blood pays an annual dividend of $0.079, resulting in a dividend yield of ―
Dividend Per Share$0.079
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.36
52-Week Price Change-16.00%
50-Day Moving Average0.94
200-Day Moving Average1.21
Relative Strength Index (RSI)55.92
Average Volume (3m)4.98K
Important Dates
Global Cord Blood upcoming earnings date is Aug 28, 2023, TBA Not Confirmed.
Last Earnings DateJun 21, 2023
Next Earnings DateAug 28, 2023
Ex-Dividend DateJul 27, 2018
Financial Position
Global Cord Blood as a current ratio of 10.73, with Debt / Equity ratio of <0.01%
Current Ratio10.73
Quick Ratio10.66
Debt to Market Cap0.00
Net Debt to EBITDA-10.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Global Cord Blood has paid 118.35M in taxes.
Income Tax118.35M
Effective Tax Rate0.19
Enterprise Valuation
Global Cord Blood EV to EBITDA ratio is -5.62, with an EV/FCF ratio of -6.22.
EV to Sales-2.97
EV to EBITDA-5.62
EV to Free Cash Flow-6.22
EV to Operating Cash Flow-6.02
Balance Sheet
Global Cord Blood has $6.67B in cash and marketable securities with ― in debt, giving a net cash position of -$6.67B billion.
Cash & Marketable Securities$6.67B
Total Debt―
Net Cash-$6.67B
Net Cash Per Share-$49.81
Tangible Book Value Per Share$39.50
Margins
Gross margin is 85.26%, with operating margin of 48.97%, and net profit margin of 40.30%.
Gross Margin85.26%
Operating Margin48.97%
Pretax Margin50.50%
Net Profit Margin40.30%
EBITDA Margin52.83%
EBIT Margin48.97%
Analyst Forecast
The average price target for Global Cord Blood is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―